Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Development of a vaccine against Rift Valley fever virus

Information

Project Team

Organisations

Outputs and Outcomes

Publications

Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults : a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial

Isabel Leroux-RoelsChittappen Kandiyil PrajeethAmare AregayNiranjana NairGuus F RimmelzwaanAlbert D M E OsterhausSimone KardinahlSabrina PelzStephan BauerValentino D'OnofrioAzhar AlhatemiBart JacobsFien De BoeverSharon PorrezGwenn WaerlopCarine PuntBart HendriksEllemieke von MauwSandra van de WaterJose Harders-WesterveenBarry RockxLucien van KeulenJeroen KortekaasGeert Leroux-RoelsPaul J Wichgers Schreur et al.

A1 Journal Article in LANCET INFECTIOUS DISEASES

2024